OSR Health (OSRHW) Operating Expenses (2022 - 2026)
OSR Health (OSRHW) posted Operating Expenses of $3.8 million for Q1 2026, down 41.25% sequentially from $6.5 million in Q4 2025, and up 20.49% YoY from $3.2 million in Q1 2025.
OSR Health (OSRHW) Operating Expenses (2022 - 2026) Analysis & Trends
OSR Health has reported Operating Expenses for 5 years, with the latest figure at $3.8 million in Q1 2026.
- Quarterly Operating Expenses rose 20.49% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.7 million (up 61.15% YoY) and the FY2025 annual result came in at $18.9 million, up 51.39% from the prior year.
- Operating Expenses slipped to $3.8 million in Q1 2026 per OSRHW's latest filing, from $6.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $6.5 million in Q4 2025 and troughed at $988.0 in Q2 2022.
- A 5-year average of $2.3 million and a median of $2.5 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2025: Operating Expenses surged 28267.71% in 2023, then slipped 11.49% in 2025.
- Over 5 years, Operating Expenses stood at $14252.0 in 2022, then soared by 5947.53% to $861894.0 in 2023, then surged by 105.71% to $1.8 million in 2024, then surged by 267.46% to $6.5 million in 2025, then plunged by 41.25% to $3.8 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $3.8 million, $6.5 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.12 Bn | 131.27 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.30 Bn | 77.31 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.66 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 55.67 Bn | 50.53 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.43 Bn | 36.33 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 27.47 Bn | 9.08 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 541.02 Mn |
| 9 | Insmed | 27.03 Bn | 25.87 Bn | 358.27 Mn | 427.03 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.83 Mn |
| Dec 31, 2025 | 6.52 Mn |
| Sep 30, 2025 | 4.06 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Mar 31, 2025 | 3.18 Mn |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 861,894.00 |
| Sep 30, 2023 | 410,431.00 |
| Jun 30, 2023 | 280,273.00 |
| Mar 31, 2023 | 278,102.00 |
| Dec 31, 2022 | 14,252.00 |
| Sep 30, 2022 | 20,022.00 |
| Jun 30, 2022 | 988.00 |